Richard S. Levy, Director at MADRIGAL PHARMACEUTICALS, INC. (MDGL), bought 3,550 shares at $15.67 ($56K) on 2017-08-21, disclosed to the SEC on 2017-08-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.67 | 900 | $14K | 25.0% |
| 2 | $15.70 | 100 | $2K | 2.8% |
| 3 | $15.72 | 100 | $2K | 2.8% |
| 4 | $15.77 | 200 | $3K | 5.6% |
| 5 | $15.79 | 200 | $3K | 5.6% |
| 6 | $15.80 | 400 |
| $6K |
| 11.2% |
| 7 | $15.90 | 10 | $159 | 0.3% |
| 8 | $15.93 | 200 | $3K | 5.7% |
| 9 | $16.02 | 200 | $3K | 5.7% |
| 10 | $16.04 | 210 | $3K | 6.0% |
| 11 | $16.07 | 440 | $7K | 12.5% |
| 12 | $16.09 | 590 | $9K | 16.8% |
| Total | $15.88 avg | 3,550 | $56K | 100% |
| Filing → |
| TARA | BUY | 2025-05-19 | $64K | — | Filing → |
| MDGL | SELL | 2024-11-08 | $1.8M | — | Filing → |
| MDGL | SELL | 2024-11-05 | $2.7M | — | Filing → |